| Date Filed | Type | Description |
| 06/02/2023 |
4
| Beckman Daniella (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 30,000 options to buy
@ $4.79, valued at
$143.7k
|
|
| 03/02/2023 |
4
| Beckman Daniella (CFO) has filed a Form 4 on Tango Therapeutics, Inc.|
Txns:
| Granted 32,842 shares
@ $0
Granted 197,051 options to buy
@ $5.2, valued at
$1M
|
|
| 06/30/2022 |
4
| Beckman Daniella (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 2,600 shares
@ $0
Granted 5,300 options to buy
@ $50.64, valued at
$268.4k
|
|
| 06/16/2022 |
4
| Beckman Daniella (Director) has filed a Form 4 on Vor Biopharma Inc.|
Txns:
| Granted 16,911 options to buy
@ $4.26, valued at
$72k
|
|
| 03/31/2022 |
4/A
| Beckman Daniella (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 3,400 shares
@ $0
Granted 7,000 options to buy
@ $98.72, valued at
$691k
|
|
| 03/31/2022 |
3/A
| Beckman Daniella (Director) has filed a Form 3/A on Blueprint Medicines Corp |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2021 |
3
| Beckman Daniella (CFO) has filed a Form 3 on Tango Therapeutics, Inc. |
| 06/16/2021 |
4
| Beckman Daniella (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 20,000 options to buy
@ $20.43, valued at
$408.6k
|
|
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/20/2020 |
4
| Beckman Daniella (Director) has filed a Form 4 on 5:01 Acquisition Corp.|
Txns:
| Acquired 30,000 options to buy
@ $0 |
|
| 10/13/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2020 |
4
| Beckman Daniella (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $15.33, valued at
$289.7k
|
|
| 06/19/2019 |
4
| Beckman Daniella (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $10.2, valued at
$192.8k
|
|
| 06/27/2018 |
3
| Beckman Daniella (Director) has filed a Form 3 on Translate Bio, Inc. |
| 08/05/2014 |
4
| Beckman Daniella (SVP, CFO and Treasurer) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 15,000 options to buy
@ $5.32, valued at
$79.8k
Disposed/sold 6,000 options to buy
@ $5.46, valued at
$32.8k
Disposed/sold 7,500 options to buy
@ $2.96, valued at
$22.2k
Disposed/sold 30,000 options to buy
@ $3.17, valued at
$95.1k
Disposed/sold 50,000 options to buy
@ $4.57, valued at
$228.5k
Disposed/sold 100,000 options to buy
@ $12.08, valued at
$1.2M
Disposed/sold 100,000 options to buy
@ $4.65, valued at
$465k
Disposed/sold 100,000 options to buy
@ $7.01, valued at
$701k
|
|
| 02/12/2014 |
4
| Beckman Daniella (SVP, CFO and Treasurer) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $7.01, valued at
$701k
|
|
| 02/22/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2012 |
4
| Beckman Daniella (SVP, CFO and Treasurer) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $12.08, valued at
$1.2M
|
|
| 06/03/2011 |
4
| Beckman Daniella (VP, CFO and Treasurer) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $4.57, valued at
$228.5k
|
|
| 06/03/2011 |
3
| Beckman Daniella (VP, CFO and Treasurer) has filed a Form 3 on IDENIX PHARMACEUTICALS INC |